Global Therapeutic Vaccines Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Therapeutic Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Therapeutic Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Therapeutic Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Therapeutic Vaccines Segment by Type

2.2.1 Peptide Therapeutic Vaccine

2.2.2 Cell Therapeutic Vaccine

2.2.3 Nucleic Acid Therapeutic Vaccine

2.3 Therapeutic Vaccines Sales by Type

2.3.1 Global Therapeutic Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Therapeutic Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Therapeutic Vaccines Sale Price by Type (2017-2022)

2.4 Therapeutic Vaccines Segment by Application

2.4.1 Oncotherapy

2.4.2 Hepatitis B

2.4.3 Tuberculosis

2.4.4 Herpes Simplex Virus

2.4.5 Others

2.5 Therapeutic Vaccines Sales by Application

2.5.1 Global Therapeutic Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Therapeutic Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Therapeutic Vaccines Sale Price by Application (2017-2022)

3 Global Therapeutic Vaccines by Company

3.1 Global Therapeutic Vaccines Breakdown Data by Company

3.1.1 Global Therapeutic Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Therapeutic Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Therapeutic Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Therapeutic Vaccines Revenue by Company (2020-2022)

3.2.2 Global Therapeutic Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Therapeutic Vaccines Sale Price by Company

3.4 Key Manufacturers Therapeutic Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Therapeutic Vaccines Product Location Distribution

3.4.2 Players Therapeutic Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Therapeutic Vaccines by Geographic Region

4.1 World Historic Therapeutic Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Therapeutic Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Therapeutic Vaccines Annual Revenue by Geographic Region

4.2 World Historic Therapeutic Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Therapeutic Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Therapeutic Vaccines Annual Revenue by Country/Region

4.3 Americas Therapeutic Vaccines Sales Growth

4.4 APAC Therapeutic Vaccines Sales Growth

4.5 Europe Therapeutic Vaccines Sales Growth

4.6 Middle East & Africa Therapeutic Vaccines Sales Growth

5 Americas

5.1 Americas Therapeutic Vaccines Sales by Country

5.1.1 Americas Therapeutic Vaccines Sales by Country (2017-2022)

5.1.2 Americas Therapeutic Vaccines Revenue by Country (2017-2022)

5.2 Americas Therapeutic Vaccines Sales by Type

5.3 Americas Therapeutic Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Therapeutic Vaccines Sales by Region

6.1.1 APAC Therapeutic Vaccines Sales by Region (2017-2022)

6.1.2 APAC Therapeutic Vaccines Revenue by Region (2017-2022)

6.2 APAC Therapeutic Vaccines Sales by Type

6.3 APAC Therapeutic Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Therapeutic Vaccines by Country

7.1.1 Europe Therapeutic Vaccines Sales by Country (2017-2022)

7.1.2 Europe Therapeutic Vaccines Revenue by Country (2017-2022)

7.2 Europe Therapeutic Vaccines Sales by Type

7.3 Europe Therapeutic Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Therapeutic Vaccines by Country

8.1.1 Middle East & Africa Therapeutic Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Therapeutic Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Therapeutic Vaccines Sales by Type

8.3 Middle East & Africa Therapeutic Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Therapeutic Vaccines

10.3 Manufacturing Process Analysis of Therapeutic Vaccines

10.4 Industry Chain Structure of Therapeutic Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Therapeutic Vaccines Distributors

11.3 Therapeutic Vaccines Customer

12 World Forecast Review for Therapeutic Vaccines by Geographic Region

12.1 Global Therapeutic Vaccines Market Size Forecast by Region

12.1.1 Global Therapeutic Vaccines Forecast by Region (2023-2028)

12.1.2 Global Therapeutic Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Therapeutic Vaccines Forecast by Type

12.7 Global Therapeutic Vaccines Forecast by Application

13 Key Players Analysis

13.1 Northeast Biotherapeutics

13.1.1 Northeast Biotherapeutics Company Information

13.1.2 Northeast Biotherapeutics Therapeutic Vaccines Product Offered

13.1.3 Northeast Biotherapeutics Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Northeast Biotherapeutics Main Business Overview

13.1.5 Northeast Biotherapeutics Latest Developments

13.2 Agenus

13.2.1 Agenus Company Information

13.2.2 Agenus Therapeutic Vaccines Product Offered

13.2.3 Agenus Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Agenus Main Business Overview

13.2.5 Agenus Latest Developments

13.3 Vaccinogen Inc

13.3.1 Vaccinogen Inc Company Information

13.3.2 Vaccinogen Inc Therapeutic Vaccines Product Offered

13.3.3 Vaccinogen Inc Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Vaccinogen Inc Main Business Overview

13.3.5 Vaccinogen Inc Latest Developments

13.4 CIMAB S.A

13.4.1 CIMAB S.A Company Information

13.4.2 CIMAB S.A Therapeutic Vaccines Product Offered

13.4.3 CIMAB S.A Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 CIMAB S.A Main Business Overview

13.4.5 CIMAB S.A Latest Developments

13.5 Dendreon

13.5.1 Dendreon Company Information

13.5.2 Dendreon Therapeutic Vaccines Product Offered

13.5.3 Dendreon Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Dendreon Main Business Overview

13.5.5 Dendreon Latest Developments

13.6 Corixa

13.6.1 Corixa Company Information

13.6.2 Corixa Therapeutic Vaccines Product Offered

13.6.3 Corixa Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Corixa Main Business Overview

13.6.5 Corixa Latest Developments

13.7 AVAX Technologies

13.7.1 AVAX Technologies Company Information

13.7.2 AVAX Technologies Therapeutic Vaccines Product Offered

13.7.3 AVAX Technologies Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 AVAX Technologies Main Business Overview

13.7.5 AVAX Technologies Latest Developments

14 Research Findings and Conclusion

Table 1. Therapeutic Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Therapeutic Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Peptide Therapeutic Vaccine

Table 4. Major Players of Cell Therapeutic Vaccine

Table 5. Major Players of Nucleic Acid Therapeutic Vaccine

Table 6. Global Therapeutic Vaccines Sales by Type (2017-2022) & (K Units)

Table 7. Global Therapeutic Vaccines Sales Market Share by Type (2017-2022)

Table 8. Global Therapeutic Vaccines Revenue by Type (2017-2022) & ($ million)

Table 9. Global Therapeutic Vaccines Revenue Market Share by Type (2017-2022)

Table 10. Global Therapeutic Vaccines Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global Therapeutic Vaccines Sales by Application (2017-2022) & (K Units)

Table 12. Global Therapeutic Vaccines Sales Market Share by Application (2017-2022)

Table 13. Global Therapeutic Vaccines Revenue by Application (2017-2022)

Table 14. Global Therapeutic Vaccines Revenue Market Share by Application (2017-2022)

Table 15. Global Therapeutic Vaccines Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global Therapeutic Vaccines Sales by Company (2020-2022) & (K Units)

Table 17. Global Therapeutic Vaccines Sales Market Share by Company (2020-2022)

Table 18. Global Therapeutic Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Therapeutic Vaccines Revenue Market Share by Company (2020-2022)

Table 20. Global Therapeutic Vaccines Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers Therapeutic Vaccines Producing Area Distribution and Sales Area

Table 22. Players Therapeutic Vaccines Products Offered

Table 23. Therapeutic Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Therapeutic Vaccines Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Therapeutic Vaccines Sales Market Share Geographic Region (2017-2022)

Table 28. Global Therapeutic Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Therapeutic Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Therapeutic Vaccines Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Therapeutic Vaccines Sales Market Share by Country/Region (2017-2022)

Table 32. Global Therapeutic Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Therapeutic Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Therapeutic Vaccines Sales by Country (2017-2022) & (K Units)

Table 35. Americas Therapeutic Vaccines Sales Market Share by Country (2017-2022)

Table 36. Americas Therapeutic Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Therapeutic Vaccines Revenue Market Share by Country (2017-2022)

Table 38. Americas Therapeutic Vaccines Sales by Type (2017-2022) & (K Units)

Table 39. Americas Therapeutic Vaccines Sales Market Share by Type (2017-2022)

Table 40. Americas Therapeutic Vaccines Sales by Application (2017-2022) & (K Units)

Table 41. Americas Therapeutic Vaccines Sales Market Share by Application (2017-2022)

Table 42. APAC Therapeutic Vaccines Sales by Region (2017-2022) & (K Units)

Table 43. APAC Therapeutic Vaccines Sales Market Share by Region (2017-2022)

Table 44. APAC Therapeutic Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Therapeutic Vaccines Revenue Market Share by Region (2017-2022)

Table 46. APAC Therapeutic Vaccines Sales by Type (2017-2022) & (K Units)

Table 47. APAC Therapeutic Vaccines Sales Market Share by Type (2017-2022)

Table 48. APAC Therapeutic Vaccines Sales by Application (2017-2022) & (K Units)

Table 49. APAC Therapeutic Vaccines Sales Market Share by Application (2017-2022)

Table 50. Europe Therapeutic Vaccines Sales by Country (2017-2022) & (K Units)

Table 51. Europe Therapeutic Vaccines Sales Market Share by Country (2017-2022)

Table 52. Europe Therapeutic Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Therapeutic Vaccines Revenue Market Share by Country (2017-2022)

Table 54. Europe Therapeutic Vaccines Sales by Type (2017-2022) & (K Units)

Table 55. Europe Therapeutic Vaccines Sales Market Share by Type (2017-2022)

Table 56. Europe Therapeutic Vaccines Sales by Application (2017-2022) & (K Units)

Table 57. Europe Therapeutic Vaccines Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Therapeutic Vaccines Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Therapeutic Vaccines Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Therapeutic Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Therapeutic Vaccines Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Therapeutic Vaccines Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Therapeutic Vaccines Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Therapeutic Vaccines Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Therapeutic Vaccines Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Therapeutic Vaccines

Table 67. Key Market Challenges & Risks of Therapeutic Vaccines

Table 68. Key Industry Trends of Therapeutic Vaccines

Table 69. Therapeutic Vaccines Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Therapeutic Vaccines Distributors List

Table 72. Therapeutic Vaccines Customer List

Table 73. Global Therapeutic Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Therapeutic Vaccines Sales Market Forecast by Region

Table 75. Global Therapeutic Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Therapeutic Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Therapeutic Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Therapeutic Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Therapeutic Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Therapeutic Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Therapeutic Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Therapeutic Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Therapeutic Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Therapeutic Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Therapeutic Vaccines Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Therapeutic Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Therapeutic Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Therapeutic Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Therapeutic Vaccines Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Therapeutic Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Therapeutic Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Therapeutic Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 93. Northeast Biotherapeutics Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 94. Northeast Biotherapeutics Therapeutic Vaccines Product Offered

Table 95. Northeast Biotherapeutics Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. Northeast Biotherapeutics Main Business

Table 97. Northeast Biotherapeutics Latest Developments

Table 98. Agenus Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 99. Agenus Therapeutic Vaccines Product Offered

Table 100. Agenus Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. Agenus Main Business

Table 102. Agenus Latest Developments

Table 103. Vaccinogen Inc Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 104. Vaccinogen Inc Therapeutic Vaccines Product Offered

Table 105. Vaccinogen Inc Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. Vaccinogen Inc Main Business

Table 107. Vaccinogen Inc Latest Developments

Table 108. CIMAB S.A Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 109. CIMAB S.A Therapeutic Vaccines Product Offered

Table 110. CIMAB S.A Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. CIMAB S.A Main Business

Table 112. CIMAB S.A Latest Developments

Table 113. Dendreon Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 114. Dendreon Therapeutic Vaccines Product Offered

Table 115. Dendreon Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. Dendreon Main Business

Table 117. Dendreon Latest Developments

Table 118. Corixa Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 119. Corixa Therapeutic Vaccines Product Offered

Table 120. Corixa Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 121. Corixa Main Business

Table 122. Corixa Latest Developments

Table 123. AVAX Technologies Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 124. AVAX Technologies Therapeutic Vaccines Product Offered

Table 125. AVAX Technologies Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 126. AVAX Technologies Main Business

Table 127. AVAX Technologies Latest Developments

List of Figures

Figure 1. Picture of Therapeutic Vaccines

Figure 2. Therapeutic Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Therapeutic Vaccines Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Therapeutic Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Therapeutic Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Peptide Therapeutic Vaccine

Figure 10. Product Picture of Cell Therapeutic Vaccine

Figure 11. Product Picture of Nucleic Acid Therapeutic Vaccine

Figure 12. Global Therapeutic Vaccines Sales Market Share by Type in 2021

Figure 13. Global Therapeutic Vaccines Revenue Market Share by Type (2017-2022)

Figure 14. Therapeutic Vaccines Consumed in Oncotherapy

Figure 15. Global Therapeutic Vaccines Market: Oncotherapy (2017-2022) & (K Units)

Figure 16. Therapeutic Vaccines Consumed in Hepatitis B

Figure 17. Global Therapeutic Vaccines Market: Hepatitis B (2017-2022) & (K Units)

Figure 18. Therapeutic Vaccines Consumed in Tuberculosis

Figure 19. Global Therapeutic Vaccines Market: Tuberculosis (2017-2022) & (K Units)

Figure 20. Therapeutic Vaccines Consumed in Herpes Simplex Virus

Figure 21. Global Therapeutic Vaccines Market: Herpes Simplex Virus (2017-2022) & (K Units)

Figure 22. Therapeutic Vaccines Consumed in Others

Figure 23. Global Therapeutic Vaccines Market: Others (2017-2022) & (K Units)

Figure 24. Global Therapeutic Vaccines Sales Market Share by Application (2017-2022)

Figure 25. Global Therapeutic Vaccines Revenue Market Share by Application in 2021

Figure 26. Therapeutic Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Therapeutic Vaccines Revenue Market Share by Company in 2021

Figure 28. Global Therapeutic Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Therapeutic Vaccines Revenue Market Share by Geographic Region in 2021

Figure 30. Global Therapeutic Vaccines Sales Market Share by Region (2017-2022)

Figure 31. Global Therapeutic Vaccines Revenue Market Share by Country/Region in 2021

Figure 32. Americas Therapeutic Vaccines Sales 2017-2022 (K Units)

Figure 33. Americas Therapeutic Vaccines Revenue 2017-2022 ($ Millions)

Figure 34. APAC Therapeutic Vaccines Sales 2017-2022 (K Units)

Figure 35. APAC Therapeutic Vaccines Revenue 2017-2022 ($ Millions)

Figure 36. Europe Therapeutic Vaccines Sales 2017-2022 (K Units)

Figure 37. Europe Therapeutic Vaccines Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Therapeutic Vaccines Sales 2017-2022 (K Units)

Figure 39. Middle East & Africa Therapeutic Vaccines Revenue 2017-2022 ($ Millions)

Figure 40. Americas Therapeutic Vaccines Sales Market Share by Country in 2021

Figure 41. Americas Therapeutic Vaccines Revenue Market Share by Country in 2021

Figure 42. United States Therapeutic Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Therapeutic Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Therapeutic Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Therapeutic Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Therapeutic Vaccines Sales Market Share by Region in 2021

Figure 47. APAC Therapeutic Vaccines Revenue Market Share by Regions in 2021

Figure 48. China Therapeutic Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Therapeutic Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Therapeutic Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Therapeutic Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Therapeutic Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Therapeutic Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Therapeutic Vaccines Sales Market Share by Country in 2021

Figure 55. Europe Therapeutic Vaccines Revenue Market Share by Country in 2021

Figure 56. Germany Therapeutic Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Therapeutic Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Therapeutic Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Therapeutic Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Therapeutic Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Therapeutic Vaccines Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Therapeutic Vaccines Revenue Market Share by Country in 2021

Figure 63. Egypt Therapeutic Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Therapeutic Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Therapeutic Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Therapeutic Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Therapeutic Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Therapeutic Vaccines in 2021

Figure 69. Manufacturing Process Analysis of Therapeutic Vaccines

Figure 70. Industry Chain Structure of Therapeutic Vaccines

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles